Julie Rose Hens

Julie Rose Hens

Auto-generated profile, based on publicly available information

Julie Rose Hens

Affiliation Department of Internal Medicine, Endocrinology and Metabolism Section, Yale University, New Haven, Connecticut, United States of America

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 August 2005 in Breast Cancer Research
Verified
Journal Article
Open access
PDF file
JHJulie R Hens
Julie R Hens
JWJohn J Wysolmerski
John J Wysolmerski
The development of the embryonic mammary gland involves communication between the epidermis and mesenchyme and is coordinated temporally and spatially by various signaling pathways. Although many more genes are likely to control mammary gland development, functional roles have been identified for Wnt, fibroblast growth factor, and parathyroid hormone-related protein signaling. This review describes what is known about the molecular mechanisms that regulate embryonic mammary gland development.

8 February 2012 in Breast Cancer Research
Verified
Journal Article
Open access
PDF file
JAJennifer L Andrews
Jennifer L Andrews
AKAlvin C Kim
Alvin C Kim
JHJulie R Hens
Julie R Hens
Cadherins are transmembrane receptors that function through calcium-dependent homophilic and heterophilic interactions that provide cell-cell contact and communication in many different organ systems. In the mammary gland only a few of the cadherins that make up this large superfamily of proteins have been characterized. Frequently in metastatic breast cancer, the genes for cadherins are epigenetically silenced, mutated, or regulated differently. During epithelial-mesenchymal transition, cadherins that are expressed normally in the epithelial cells are down-regulated, while cadherins expressed in the mesenchyme are up-regulated. This process is known as cadherin switching, and its regulation can sometimes facilitate the increased motility, invasiveness and proliferation that occurs in metastatic cancer cells. Depending on the context, however, cell motility, invasiveness, proliferation and expression of mesenchymal markers can be independently modulated from cadherin expression, leading to partial epithelial-mesenchymal transitions and even mesenchymal-epithelial transitions (METs). This review will summarize the current understanding of cadherins found in the mammary gland and what is known about their mechanism of regulation in the mammary gland during normal physiological conditions and in breast cancer.

1 January 2016 in Annals of the New York Academy of Sciences
Verified
Journal Article
Closed access
PDF file
GAGene P. Ables
Gene P. Ables
JHJulie R. Hens
Julie R. Hens
SNSailendra Nichenametla
Sailendra Nichenametla

15 December 2025 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JHJulie Rose Hens
Julie Rose Hens
SBStacey Brown
Stacey Brown
PLPawel Licznerski
Pawel Licznerski
JSJacqueline Suarez
Jacqueline Suarez
EJElizabeth Jonas
Elizabeth Jonas
JWJohn J. Wysolmerski
John J. Wysolmerski
GABBR1 and GABBR2 are widely expressed in the brain and genetic inhibition of their function leads to neurologic dysfunction and premature death in mice. Given that GABBR1 and GABBR2 heterodimerize to form a functional receptor, global knockout of GABBR1 or GABBR2 results in a similar phenotype, characterized by spontaneous epileptiform activity, hyperlocomotor activity, hyperalgesia, impaired memory and premature death. Both GABBR1 and GABBR2 are expressed in a variety of tissues outside the nervous system and GABA-B receptors have been shown to heterodimerize with other class C GPCRs. However, the neurologic consequences of global GABBR1 or GABBR2 knockout mice have made it difficult to study the effects of loss of GABBR function in other organs. While a conditional knockout for GABBR1 is available, the Gabbr2 gene had not been “floxed”. Therefore, we used CRISPR to insert loxP sites into the Gabbr2 locus in mice. These mice are normal at baseline but when bred with mice expressing Cre-recombinase under the control of the ubiquitously expressed Actin gene promoter, Gabbr2 lox/lox mice recapitulate the phenotype of global GABBR2 knockout mice demonstrating alterations throughout the brain, including the cortex, hippocampus and cerebellum. We document abnormal neurological function, increased neuronal cell death, changes in neuronal architecture, and premature death. These mice should be useful tools to study cell type-specific loss of GABBR2 function in the brain and other organs.

1 June 2008 in Journal of Histotechnology
Verified
Journal Article
Closed access
PDPamela Dann
Pamela Dann
JHJulie R. Hens
Julie R. Hens
NTNancy W. Troiano
Nancy W. Troiano
JWJohn J. Wysolmerski
John J. Wysolmerski
MKMelissa A. Kacena
Melissa A. Kacena

23 January 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
JHJulie R. Hens
Julie R. Hens
SBStacey Brown
Stacey Brown
PLPawel Licznerski
Pawel Licznerski
JSJacqueline Suarez
Jacqueline Suarez
EJElizabeth Jonas
Elizabeth Jonas
JWJohn J. Wysolmerski
John J. Wysolmerski
GABBR1 and GABBR2 are widely expressed in the brain and genetic inhibition of their function leads to widespread neurologic dysfunction and premature death in mice. Given that GABBR1 and GABBR2 heterodimerize to form a functional receptor, global knockout of GABBR1 or GABBR2 results in a similar phenotype, characterized by spontaneous epileptiform activity, hyperlocomotor activity, hyperalgesia, impaired memory and premature death. It is now known that both GABBR1 and GABBR2 are expressed in a variety of tissues outside the nervous system and that GABA-B receptors can heterodimerize with other class C GPCRs, including the extracellular calcium-sensing receptor (CaSR). Studies in vitro have demonstrated that interactions with GABBR1 and GABBR2 can alter CaSR signaling in human embryonic kidney cells and breast cancer cells. The neurologic consequences of global loss of function of GABBR1 or GABBR2 has made it difficult to study the effects of loss of GABBR function in other organs. While a conditional knockout for GABBR1 is available, the GABBR2 gene had not been “floxed”. We have used CRISPR to insert loxP sites into the GABBR2 locus in mice. These mice are normal at baseline but when bred with mice expressing Cre-recombinase under the control of the ubiquitously expressed Actin gene promoter, they recapitulate the phenotype of global GABBR2 knockout mice. Phenotypic changes through the brain, including the cortex, hippocampus and cerebellum. Evidence of abnormal neuronal function, increase cell death, and changes in neuronal architecture are seen throughout the brain of CRISPR knockout mice. These mice should be useful tools to study cell type-specific loss of GABBR2 function in the brain and other organs.